Neuberger Berman Group’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.04M | Sell |
13,214
-561
| -4% | -$47.7K | ﹤0.01% | 1512 |
|
|
2026
Q1 | $1.19M | Buy |
13,775
+679
| +5% | +$60.9K | ﹤0.01% | 1351 |
|
|
2025
Q4 | $1.14M | Buy |
13,096
+284
| +2% | +$21.6K | ﹤0.01% | 1359 |
|
|
2025
Q3 | $734K | Sell |
12,812
-351
| -3% | -$20.2K | ﹤0.01% | 1461 |
|
|
2025
Q2 | $777K | Buy |
13,163
+374
| +3% | +$24.2K | ﹤0.01% | 1434 |
|
|
2025
Q1 | $936K | Buy |
12,789
+255
| +2% | +$21.1K | ﹤0.01% | 1341 |
|
|
2024
Q4 | $1.04M | Buy |
12,534
+130
| +1% | +$10.3K | ﹤0.01% | 1303 |
|
|
2024
Q3 | $887K | Sell |
12,404
-64
| -0.5% | -$4.52K | ﹤0.01% | 1334 |
|
|
2024
Q2 | $854K | Buy |
12,468
+41
| +0.3% | +$2.45K | ﹤0.01% | 1324 |
|
|
2024
Q1 | $667K | Sell |
12,427
-12,885
| -51% | -$693K | ﹤0.01% | 1397 |
|
|
2023
Q4 | $1.35M | Buy |
25,312
+14,639
| +137% | +$713K | ﹤0.01% | 1398 |
|
|
2023
Q3 | $530K | Buy |
10,673
+6,281
| +143% | +$351K | ﹤0.01% | 1442 |
|
|
2023
Q2 | $262K | Sell |
4,392
-24
| -0.5% | -$1.37K | ﹤0.01% | 1641 |
|
|
2023
Q1 | $250K | Sell |
4,416
-5,479
| -55% | -$351K | ﹤0.01% | 1654 |
|
|
2022
Q4 | $735K | Buy |
9,895
+942
| +11% | +$64.1K | ﹤0.01% | 1335 |
|
|
2022
Q3 | $534K | Buy |
8,953
+2,999
| +50% | +$181K | ﹤0.01% | 1448 |
|
|
2022
Q2 | $334K | Buy |
5,954
+41
| +0.7% | +$2.69K | ﹤0.01% | 1607 |
|
|
2022
Q1 | $436K | Buy |
5,913
+35
| +0.6% | +$2.43K | ﹤0.01% | 1575 |
|
|
2021
Q4 | $424K | Buy |
5,878
+1,840
| +46% | +$134K | ﹤0.01% | 1597 |
|
|
2021
Q3 | $309K | Buy |
4,038
+132
| +3% | +$10.6K | ﹤0.01% | 1597 |
|
|
2021
Q2 | $303K | Buy |
3,906
+209
| +6% | +$14.9K | ﹤0.01% | 1611 |
|
|
2021
Q1 | $228K | Sell |
3,697
-399
| -10% | -$25.3K | ﹤0.01% | 1674 |
|
|
2020
Q4 | $267K | Sell |
4,096
-35
| -0.8% | -$2.01K | ﹤0.01% | 1546 |
|
|
2020
Q3 | $205K | Buy |
+4,131
| New | +$213K | ﹤0.01% | 1555 |
|
|
2015
Q4 | – | Sell |
-41,521
| Closed | -$858K | – | 1520 |
|
|
2015
Q3 | $858K | Sell |
41,521
-26,979
| -39% | -$683K | ﹤0.01% | 1193 |
|
|
2015
Q2 | $1.76M | Buy |
68,500
+1,600
| +2% | +$40.5K | ﹤0.01% | 1087 |
|
|
2015
Q1 | $1.69M | Buy |
66,900
+17,400
| +35% | +$424K | ﹤0.01% | 1103 |
|
|
2014
Q4 | $1.18M | Buy |
+49,500
| New | +$1.1M | ﹤0.01% | 1190 |
|
|
2014
Q1 | – | Sell |
-51,400
| Closed | -$1.04M | – | 1635 |
|
|
2013
Q4 | $1.04M | Sell |
51,400
-31,400
| -38% | -$583K | ﹤0.01% | 1207 |
|
|
2013
Q3 | $1.45M | Sell |
82,800
-284,303
| -77% | -$4.92M | ﹤0.01% | 1127 |
|
|
2013
Q2 | $6.19M | Buy |
+367,103
| New | +$5.67M | 0.01% | 852 |
|
Other funds holding GMED
JT
SC
Neuberger Berman Group's GMED Position: Q2 2026 in Review
Neuberger Berman Group reduced its Globus Medical (GMED) stake by 4.1% in Q2 2026, selling an estimated $47.7K and leaving 13,214 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1512.
Neuberger Berman Group first reported a position in GMED in Q2 2013 and has held it in 31 quarters since. The position peaked at $6.19M in Q2 2013. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Neuberger Berman Group held 13,214 shares of Globus Medical worth $1.04M as of Q2 2026.
- Neuberger Berman Group sold 561 Globus Medical shares in Q2 2026, an estimated $47.7K.
- Globus Medical made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1512 holding.
- Neuberger Berman Group first reported a position in Globus Medical in Q2 2013 and has held it in 31 quarters since.
- Neuberger Berman Group's Globus Medical position peaked at $6.19M in Q2 2013.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.